CancerfromBoston.com6 days agoEli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion dealEli Lilly will acquire Kelonia Therapeutics for $7 billion to enhance its cancer treatment capabilities in Massachusetts.
Medicinefromenglish.elpais.com3 months agoThe pastry chef who patented an anti-cancer molecule that's been bought for over $8 billionPetosemtamab, co-invented by Eduard Batlle, achieved high response rates and complete remissions in head and neck cancer trials and was sold to Genmab.